Genetic cause of ALS and frontotemporal dementia blocked by RNA-binding compound, with potential to become a drug to treat both diseases. “There are zero therapies that address the root cause of this disease. Our goal is not to target the symptoms, it is to target the root cause, which is that RNA.”

Genetic cause of ALS and frontotemporal dementia blocked by RNA-binding compound, with potential to become a drug to treat both diseases. “There are zero therapies that address the root cause of this disease. Our goal is not to target the symptoms, it is to target the root cause, which is that RNA.”: https://ift.tt/2A38MWU Read more... https://ift.tt/2GvBMMv